Transport of leuprolide across rat intestine, rabbit intestine and Caco-2 cell monolayer

被引:23
作者
Guo, J
Ping, Q [1 ]
Jiang, G
Dong, J
Qi, S
Feng, L
Li, Z
Li, C
机构
[1] China Pharmaceut Univ, Dept Pharmaceut, Nanjing 210009, Peoples R China
[2] BD Technol, Res Triangle Pk, NC 27709 USA
[3] Nanjing Normal Univ, Key Lab Mol & Med Biol, Nanjing 210097, Peoples R China
基金
中国国家自然科学基金;
关键词
leuprolide; transport; trypsin inhibitor; chitosan; everted gut sac technique; Caco-2; cell;
D O I
10.1016/j.ijpharm.2004.03.031
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to investigate the transport mechanisms and causes of low bioavailability of leuprolide. The everted gut sac technique and Caco-2 cell monolayer were used to examine: (1) transport properties, enzyme degradation and apparent permeation coefficient (P-app); (2) the influence of trypsin inhibitor, EDTA, chitosan and alginate on drug transport; and (3) the effect of animal species on the intestinal transport. Results showed flux increased with increasing concentration of drug, showing a passive diffusion pathway. The enzyme degradation in rabbit gut was the highest. The P-app of (4.19 +/- 1.33) x 10(-5) cm/s in rat gut was the largest and the P-app of (5.20 +/- 0.20) x 10(-7) cm/s in Caco-2 cell the smallest. At a low concentration of drug. trypsin inhibitor had strong enhancement effect on the P-app by protecting enough drug for permeation. Chitosan had no effect on the activity of alpha-chymotrypsin. The increase in P-app was due to opening of the tight junctions and interaction with cells. In conclusion, both inhibition of proteolytic enzymes and opening the tight junctions to allow for paracellular transport improved the intestinal absorption. At low drug concentration, reduction of enzyme degradation is the most important factor. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:415 / 422
页数:8
相关论文
共 18 条
  • [1] BIOAVAILABILITY OF LEUPROLIDE ACETATE FOLLOWING NASAL AND INHALATION DELIVERY TO RATS AND HEALTHY HUMANS
    ADJEI, A
    SUNDBERG, D
    MILLER, J
    CHUN, A
    [J]. PHARMACEUTICAL RESEARCH, 1992, 9 (02) : 244 - 249
  • [2] Effect of Formulation Adjuvants on Gastrointestinal Absorption of Leuprolide Acetate
    Adjei, A.
    Love, S.
    Johnson, E.
    Diaz, G.
    Greer, J.
    Haviv, F.
    Bush, E.
    [J]. JOURNAL OF DRUG TARGETING, 1993, 1 (03) : 251 - 258
  • [3] Gastrointestinal absorption of drugs: methods and studies
    Barthe, L
    Woodley, J
    Houin, G
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1999, 13 (02) : 154 - 168
  • [4] EXPRESSION AND PROTEIN-KINASE C-DEPENDENT REGULATION OF PEPTIDE/H+ COTRANSPORT SYSTEM IN THE CACO-2 HUMAN COLON-CARCINOMA CELL-LINE
    BRANDSCH, M
    MIYAMOTO, Y
    GANAPATHY, V
    LEIBACH, FH
    [J]. BIOCHEMICAL JOURNAL, 1994, 299 : 253 - 260
  • [5] DEBOER A, 1991, PHARM RES, V8, pS215
  • [6] FULU M, 1992, PHARM RES, V9, P1575
  • [7] MECHANISM OF INTESTINAL-ABSORPTION OF RANITIDINE AND ONDANSETRON - TRANSPORT ACROSS CACO-2 CELL MONOLAYERS
    GAN, LS
    HSYU, PH
    PRITCHARD, JF
    THAKKER, D
    [J]. PHARMACEUTICAL RESEARCH, 1993, 10 (12) : 1722 - 1725
  • [8] STABILIZATION OF THE N-TERMINAL RESIDUES OF LUTEINIZING-HORMONE-RELEASING HORMONE AGONISTS AND THE EFFECT ON PHARMACOKINETICS
    HAVIV, F
    FITZPATRICK, TD
    NICHOLS, CJ
    SWENSON, RE
    BUSH, EN
    DIAZ, G
    NGUYEN, A
    NELLANS, HN
    HOFFMAN, DJ
    GHANBARI, H
    JOHNSON, ES
    LOVE, S
    CYBULSKI, V
    GREER, J
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (21) : 3890 - 3894
  • [9] TRANSPORT OF A LARGE NEUTRAL AMINO-ACID (PHENYLALANINE) IN A HUMAN INTESTINAL EPITHELIAL-CELL LINE - CACO-2
    HIDALGO, IJ
    BORCHARDT, RT
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1028 (01) : 25 - 30
  • [10] Chitosan: properties, preparations and application to microparticulate systems
    Kas, HS
    [J]. JOURNAL OF MICROENCAPSULATION, 1997, 14 (06) : 689 - 711